5323-89-7 Usage
Uses
Used in Pharmaceutical Research:
(6,6-dimethylbicyclo[3.1.1]hept-2-yl)acetic acid is utilized as a key building block in the synthesis of various pharmaceutical compounds, particularly in the field of neuropharmacology. Its unique structure allows for the development of drugs targeting neurological disorders and conditions.
Used in Organic Synthesis:
In the field of organic synthesis, (6,6-dimethylbicyclo[3.1.1]hept-2-yl)acetic acid is employed as an essential component for constructing a wide range of organic compounds. Its carboxylic acid functional group facilitates numerous chemical reactions, enabling the creation of diverse molecules with specific properties and applications.
Used in Materials Science:
(6,6-dimethylbicyclo[3.1.1]hept-2-yl)acetic acid holds potential in materials science, where its distinctive structure and properties can be harnessed to develop novel materials with specific characteristics. These materials could find applications in various industries, such as electronics, aerospace, or automotive.
Used in Specialty Chemicals Production:
(6,6-dimethylbicyclo[3.1.1]hept-2-yl)acetic acid also finds application in the production of specialty chemicals, where its unique properties can be leveraged to create high-value products for specific industrial applications. These specialty chemicals may include additives, coatings, or other advanced materials with tailored properties.
Check Digit Verification of cas no
The CAS Registry Mumber 5323-89-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,3,2 and 3 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 5323-89:
(6*5)+(5*3)+(4*2)+(3*3)+(2*8)+(1*9)=87
87 % 10 = 7
So 5323-89-7 is a valid CAS Registry Number.
5323-89-7Relevant academic research and scientific papers
Potassium Channel Modulators
-
, (2012/05/21)
Disclosed herein are KCNQ potassium channels modulators of formula (I) wherein R1, R2, R3, R4, and R5 are as defined in the specification. Compositions comprising such compounds; and methods for treating conditions and disorders using such compounds and compositions are also described.
Potassium Channel Modulators
-
, (2012/05/21)
Disclosed herein are KCNQ potassium channels modulators of formula (I) wherein G1, R2, R1a, R1b, X, X1, X2, X3, Rx, J, k, n, q, and t are as defined in the specification. Compositions comprising such compounds; and methods for treating conditions and disorders using such compounds and compositions are also described.